Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Targeting and modulating infarct macrophages with hemin formulated in designed lipid-based particles improves cardiac remodeling and function.

Ben-Mordechai T, Kain D, Holbova R, Landa N, Levin LP, Elron-Gross I, Glucksam-Galnoy Y, Feinberg MS, Margalit R, Leor J.

J Control Release. 2017 Jul 10;257:21-31. doi: 10.1016/j.jconrel.2017.01.001. Epub 2017 Jan 5.

PMID:
28065861
2.

Targeting macrophage subsets for infarct repair.

Ben-Mordechai T, Palevski D, Glucksam-Galnoy Y, Elron-Gross I, Margalit R, Leor J.

J Cardiovasc Pharmacol Ther. 2015 Jan;20(1):36-51. doi: 10.1177/1074248414534916. Epub 2014 Jun 17. Review.

PMID:
24938456
3.

The bacterial quorum-sensing signal molecule N-3-oxo-dodecanoyl-L-homoserine lactone reciprocally modulates pro- and anti-inflammatory cytokines in activated macrophages.

Glucksam-Galnoy Y, Sananes R, Silberstein N, Krief P, Kravchenko VV, Meijler MM, Zor T.

J Immunol. 2013 Jul 1;191(1):337-44. doi: 10.4049/jimmunol.1300368. Epub 2013 May 29.

4.

Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response.

Glucksam-Galnoy Y, Zor T, Margalit R.

J Control Release. 2012 Jun 10;160(2):388-93. doi: 10.1016/j.jconrel.2011.10.008. Epub 2011 Oct 12.

PMID:
22019559

Supplemental Content

Loading ...
Support Center